SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Eli Lilly -- Ignore unavailable to you. Want to Upgrade?

To: Robert Voigt who wrote (96)3/25/1998 11:40:00 AM
From: Quonnie  Respond to of 642
 
Hello, I am very surprise the LLY is being downgraded by poor performance of this new drug...I am looking to just into LLY and might have a good opportunity very shortly. split was $60 a few months ago and now it is at this threshold so I would say anything below $60 is a good point to buy into LLY. Just my two cents..Quonnie Go LLY!



To: Robert Voigt who wrote (96)3/25/1998 11:41:00 AM
From: Proton  Respond to of 642
 
Re: Lilly Downgrade

Heuer also said that there were no major rollouts form LLY's pipeline for 2-3 more years.

LLY avoided the February 18 low at 59 1/2. That now looks like critical support. Today's low (so far) is 59 7/8, just enough to hit stops at 60. :-)

Pý


HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News